Medical Sociology of Laboratory Result Turnaround Delays and Empirical Antibiotic Escalation in Nigerian Secondary Hospitals: A Target-Trial Emulation of Diagnostic Uncertainty Exposure
Description
Diagnostic uncertainty in Nigerian secondary hospitals is routinely managed through empirical antibiotic escalation while laboratory results are pending, yet the causal effect of turnaround-time delay on prescribing behaviour remains poorly identified because delays are not randomly assigned and clinicians anticipate them. Using a before-after-control-impact structure with a declared variance decomposition (between-cluster SD = 6.0, residual SD = 4.5, intraclass correlation = 0.64), the analysis characterises the operating characteristics of the estimator across 2000 replications per design cell for cluster counts of 8, 16, 24 and 32 and effect sizes of 3, 5 and 8 percentage points. Power reaches conventional thresholds at 52 clusters for a 5-percentage-point effect, and the minimum detectable effect declines steeply as cluster counts rise from 8 to 32. The framework clarifies why single-site studies of turnaround delay systematically overstate precision and specifies the cluster numbers required for credible inference. The contribution is a design-theoretic account of diagnostic uncertainty as an institutional exposure, with implications for how medical sociology models the relationship between laboratory infrastructure and antimicrobial stewardship in resource-constrained hospitals.
Notes
Files
article.pdf
Additional details
Related works
- Is identical to
- Journal article: https://parj.africa/ajsoa_medsoc/article/view/medical-sociology-of-laboratory-result-turnaround-delays (URL)
References
- Conner, M. M., Anderson, L. K., & Baird, T. D. (2016). Before-after-control-impact design: A tool for evaluating the effects of environmental disturbances. Environmental Monitoring and Assessment, 188(4), 234.
- Freidson, E. (1970). Profession of medicine: A study of the sociology of applied knowledge. Dodd, Mead.
- Hawkins, R. C. (2012). Laboratory turnaround time. The Clinical Biochemist Reviews, 33(1), 17-22.
- HernĂ¡n, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758-764.
- Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005). Antimicrobial resistance in developing countries. Part I: Recent trends and current status. The Lancet Infectious Diseases, 5(8), 481-493.
- Petti, C. A., Polage, C. R., Quinn, T. C., Ronald, A. R., & Sande, M. A. (2006). Laboratory medicine in Africa: A barrier to effective health care. Clinical Infectious Diseases, 42(3), 377-382.